AzTrials
AzTrials

AnesthesiaEarly Phase 1NCT07169032

The Effect of Er,Cr:YSGG Laser-assisted Topical Anesthetic on Oral Mucosal Anesthesia

A Early Phase 1 study testing Er,Cr:YSGG laser irradiation, Lidocaine and Vaseline in people with Anesthesia, run by Li Zhen Zhong at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study tests whether using an Er,Cr:YSGG laser before applying numbing gel (lidocaine) can help reduce pain during dental procedures compared to traditional methods. Investigators want to know: Does the laser make the numbing gel work better and longer? Does it lower pain and keep patients calmer (measured by… Read more about this study

Who is it for?
Ages 20 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Anesthesia
What is being tested?
Er,Cr:YSGG laser irradiation, Lidocaine and Vaseline
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
20 participants
Where
1 siteChina
Study dates
1 Jan 2024to 21 Feb 2024
Phase
Early Phase 1
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • could understand and follow given instructions

Who cannot join

  • excessive dental anxiety
  • anesthesia allergies
  • mucosal lesions
  • cardiovascular disease
  • diabetes
  • pregnancy or lactation
Show all 9Show fewer
  • severe psychiatric disorders
  • hearing abnormalities
  • speech dysfunction

Trial locations and contacts

1 site in 1 country.

China1 site
  • the First Affiliated Hospital of Jinan University

    Guangzhou, Guangdong, 510000

Other trials in China

About this study

This study tests whether using an Er,Cr:YSGG laser before applying numbing gel (lidocaine) can help reduce pain during dental procedures compared to traditional methods. Investigators want to know:

Does the laser make the numbing gel work better and longer?

Read more

Does it lower pain and keep patients calmer (measured by heart rate)?

Investigators enrolled 20 adults (10 men, 10 women) and assigned them to three groups:

Laser + Numbing Gel: Laser was used on the gums before applying lidocaine.

Sham Laser + Numbing Gel: A fake laser was used with lidocaine.

Sham Laser + Vaseline: A fake laser was used with Vaseline (no numbing effect).

Participants reported pain levels on a scale (0=no pain, 10=worst pain) when a tiny needle touched their gums. Investigators also checked their heart rate.

Read the detailed description

Participants will be invited to participate in a study observing the anesthetic efficacy of the combination of Er,Cr:YSGG laser and surface anesthetic agent on the oral mucosa. This informed consent form provides participants with detailed information to help participants decide whether to participate in this project. Please read it carefully. If participants have any questions, please raise them to the researcher in charge of the study. Investigators will give participants a comprehensive explanation.

Participants' participation in this study is voluntary. This research has been reviewed by the ethics committee of this research institution.

Research purpose: By measuring the anesthetic depth of the combined use of Er,Cr:YSGG water laser and surface anesthetic agent at different time points in the oral vestibule of the mandibular anterior teeth area, to observe the anesthetic efficacy of the combined use of Er,Cr:YSGG water laser and surface anesthetic agent on the oral mucosa.

Research content and process: Before participants are selected for the study, the doctor will ask about participants basic situation, record participants' medical history, and conduct a routine oral examination. The specific requirements are: no allergy to anesthetic drugs, no mucosal lesions, no pregnancy, no systemic diseases, and good health condition.

If participants' above examinations are qualified, participants will follow the following steps for the study: Rest for half an hour to stabilize blood pressure and heart rate. The nurse will put an electrocardiogram monitor on participants to record the changes in blood pressure and heart rate throughout the process. The doctor will select three sites in the vestibule of the mandibular anterior teeth area and irradiate 1 cm away from the site at a 90-degree angle with water laser or ineffective laser for 1 minute, and then randomly apply lidocaine or vaseline to the three sites. The subjects will not rinse their mouths during the experiment. The doctor will insert an aseptic needle into the mucosa at three sites in the mandibular anterior teeth area 10 minutes, 20 minutes, 30 minutes, 40 minutes and 50 minutes after irradiation, and the subjects will raise their hands to indicate "feeling" or "pain" to stop the needle insertion. The doctor will record the depth of needle insertion.

After the anesthesia, the doctor will check the wound. The doctor will visit the subject's numbness and record the anesthetic duration. Observe whether there are itching, pain, redness and swelling in the wound.

Risks and discomforts: A few people in this clinical experiment may have discomfort symptoms such as itching, pain, and redness. If these discomforts occur, the doctor will handle them promptly. Participants' relevant information will be kept confidential. Investigators will do our best to minimize the possibility of participants' information being exposed.

Benefits of participating in this study: Participants will receive a free panoramic X-ray, full-mouth examination, and supra-gingival scaling.

Cost: The relevant research costs for this project will be borne by the research group. Participants do not need to bear the relevant costs for the research process itself, and it will not increase participants' additional medical treatment costs. If physical harm is caused to participants due to the research itself, the additional medical treatment costs will be compensated or compensated in accordance with relevant national laws and regulations.

As a research subject, participants need to: Provide the true situation of participants' own medical history and current physical condition; Tell the researcher of any discomforts participants experience during this study; Tell the researcher whether participants have participated in other studies recently or are currently participating in other studies, and other matters that may affect the research results or participants' health.

Privacy issue: If participants decide to participate in this study, participants' participation in the trial and participants' personal information during the trial will be kept confidential. Participants' identity information will not be disclosed to members outside the research group unless participants give participants' permission. All research members and the research sponsor are required to keep participants' identity confidential. Participants' file will be stored in a locked filing cabinet and only available for researchers to consult. To ensure the research is conducted in accordance with regulations, when necessary, members of government management departments or ethics review committees will be able to consult participants' personal information at the research institution. When the research results are published, no personal information of participants will be disclosed.

Participants have the right to choose not to participate in this study. During the research process, participants also have the right to withdraw at any time without any reason. Investigators will decide whether the obtained data will be included in the research results according to participants' wishes and the needs of the research. Participants' any rights will not be affected in this case.

If participants need other treatments, or participants fail to follow the research plan, or there is any injury related to the research or any other reasons, the researcher can terminate participants' participation in this study.

Participants can always obtain information about themselves and the progress of this research. If participants have any questions related to this research, or if participants experience any discomfort or injury during the research process, or if participants have any questions regarding the rights of participants in this study, please contact the researcher by phone or other means in a timely manner.

Conditions
Anesthesia
Being tested
Er,Cr:YSGG laser irradiation, Sham Laser irradiation, Lidocaine, Vaseline
Keywords
Er,Cr:YSGG laser, needle-free anesthesia, dental anxiety, oral mucosal anesthesia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Er,Cr:YSGG laser irradiationDevice

    irradiation with a 2780 nm, 1.0 W Er,Cr:YSGG laser for 1 minute

  • Sham Laser irradiationDrug

    sham laser irradiation for 1 minute

  • LidocaineDrug

    2% lidocaine gel

  • VaselineDrug

    Vaseline

Study groups in NCT07169032
Study groupRoleWhat they receive
Laser + LidocaineExperimentalOne of three sites in the vestibular groove of the mandibular anterior teeth region of each participant received irradiation with a 2780 nm, 1.0 W Er,Cr:YSGG laser for 1 minute followed by application of 2% lidocaine gel.
Receives: Device: Er,Cr:YSGG laser irradiation; Drug: Lidocaine
Sham Laser + LidocaineSham comparatorOne of three sites in the vestibular groove of the mandibular anterior teeth region of each participant received sham laser irradiation for 1 minute followed by application of 2% lidocaine gel.
Receives: Drug: Sham Laser irradiation; Drug: Lidocaine
Sham Laser + VaselinePlacebo comparatorOne of three sites in the vestibular groove of the mandibular anterior teeth region of each participant received sham laser irradiation for 1 minute followed by application of Vaseline.
Receives: Drug: Sham Laser irradiation; Drug: Vaseline

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Insertion Depth at Initial Sensory Detection

    Insert a sterile needle into the mucosa at the sites. Record the Insertion depth when participants perceived an "initial sensory detection"

    Measured: 10, 20, 30, 40, and 50 minutes

  2. Insertion Depth at Pain

    Insert a sterile needle into the mucosa at the sites. Record the Insertion depth when participants felt "pain".

    Measured: 10, 20, 30, 40, and 50 minutes

  3. Pain Score at Initial Sensory Detection

    Insert a sterile needle into the mucosa at the sites. Record the pain score when participants perceived an "initial sensory detection". Evaluated with a linear visual analog scale. "0" represents no pain, and "10" represents the most intense pain imaginable.

    Measured: 10, 20, 30, 40, and 50 minutes

  4. Pain Score at Pain

    Insert a sterile needle into the mucosa at the sites. Record the pain score when participants felt "pain". Evaluated with a linear visual analog scale. "0" represents no pain, and "10" represents the most intense pain imaginable.

    Measured: 10, 20, 30, 40, and 50 minutes

  5. Heart Rate

    Insert a sterile needle into the mucosa at the sites. Record the heart rate with an electrocardiogram monitor when participants felt "pain".

    Measured: 10, 20, 30, 40, and 50 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Sep 2025
  2. Study start1 Jan 2024
  3. Primary completion20 Feb 2024
  4. Study completion21 Feb 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07169032
Sponsor's protocol ID
JNUKY-2023-0149
Status last verified
Nov 2025
First submitted
4 Sep 2025
Last updated
4 Dec 2025
Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
Yes
Individual data sharing
Yes

Publications

  • Khalighi HR, Mojahedi M, Parandoosh A. Efficacy of Er,Cr:YSGG laser-assisted delivery of topical anesthesia in the oral mucosa. Clin Oral Investig. 2021 Mar;25(3):1055-1058. doi: 10.1007/s00784-020-03399-x. Epub 2020 Jun 18.

    PubMed 32556664

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing Er,Cr:YSGG laser irradiation, Lidocaine and Vaseline in people with Anesthesia, run by Li Zhen Zhong at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Yes. Results are posted in the registry (first posted 4 Dec 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Insertion Depth at Initial Sensory Detection (time frame: 10, 20, 30, 40, and 50 minutes). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07169032, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in